174 related articles for article (PubMed ID: 36479666)
1. Enhanced MCM5 Level Predicts Bad Prognosis in Acute Myeloid Leukemia.
Wang S; Wu W; Han X
Mol Biotechnol; 2023 Aug; 65(8):1242-1252. PubMed ID: 36479666
[TBL] [Abstract][Full Text] [Related]
2. A transient receptor potential channel-related model based on machine learning for evaluating tumor microenvironment and immunotherapeutic strategies in acute myeloid leukemia.
Hua J; Ding T; Shao Y
Front Immunol; 2022; 13():1040661. PubMed ID: 36591215
[TBL] [Abstract][Full Text] [Related]
3. A Prognostic Model of Pseudogenes in Acute Myeloid Leukemia.
Jian J; Wang X; Hao H; Ji C; Yuan C; Lu F
Clin Lab; 2023 May; 69(5):. PubMed ID: 37145087
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of an eighteen-genes panel in acute myeloid leukemia by analyzing TARGET and TCGA databases.
Chen P; Cao J; Chen L; Gao G; Xu Y; Jia P; Li Y; Li Y; Du J; Zhang S; Zhang J
Cancer Biomark; 2023; 36(4):287-298. PubMed ID: 36938728
[TBL] [Abstract][Full Text] [Related]
5. SPINK2 is a prognostic biomarker related to immune infiltration in acute myeloid leukemia.
Chen X; Zhao L; Yu T; Zeng J; Chen M
Am J Transl Res; 2022; 14(1):197-210. PubMed ID: 35173838
[TBL] [Abstract][Full Text] [Related]
6. Low expression of the metabolism-related gene SLC25A21 predicts unfavourable prognosis in patients with acute myeloid leukaemia.
Wang W; Liang Q; Zhao J; Pan H; Gao Z; Fang L; Zhou Y; Shi J
Front Genet; 2022; 13():970316. PubMed ID: 36246603
[TBL] [Abstract][Full Text] [Related]
7. High expression of COMMD7 is an adverse prognostic factor in acute myeloid leukemia.
Li K; Chen L; Zhang H; Wang L; Sha K; Du X; Li D; Zheng Z; Pei R; Lu Y; Tong H
Aging (Albany NY); 2021 Apr; 13(8):11988-12006. PubMed ID: 33891561
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive analysis of nucleotide excision repair characteristics defines a novel prognostic signature for acute myeloid leukemia.
Bu XX; Cong J; Ling L; Lu BB; Wu CY; Jiang F; Wang ZM; Chen J
Eur Rev Med Pharmacol Sci; 2023 Aug; 27(15):6917-6930. PubMed ID: 37606102
[TBL] [Abstract][Full Text] [Related]
9. The signature based on seven genomic instability-related genes could predict the prognosis of acute myeloid leukemia patients.
Nie L; Zhang Y; You Y; Lin C; Li Q; Deng W; Ma J; Luo W; He H
Hematology; 2022 Dec; 27(1):840-848. PubMed ID: 35924822
[TBL] [Abstract][Full Text] [Related]
10. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia.
Song Y; Zhang W; He X; Liu X; Yang P; Wang J; Hu K; Liu W; Zhang X; Jing H; Yuan X
J Transl Med; 2019 May; 17(1):166. PubMed ID: 31109331
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of RASGEF1A RNA expression and DNA methylation in cytogenetically normal acute myeloid leukemia.
He X; Zhang W; Fu W; Liu X; Yang P; Wang J; Zhu M; Li S; Zhang W; Zhang X; Dong G; Yan C; Zhao Y; Zeng Z; Jing H
Cancer Biomark; 2023; 36(2):103-116. PubMed ID: 36404533
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation-based prognostic biomarkers of acute myeloid leukemia patients.
Hu L; Gao Y; Shi Z; Liu Y; Zhao J; Xiao Z; Lou J; Xu Q; Tong X
Ann Transl Med; 2019 Dec; 7(23):737. PubMed ID: 32042753
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic implications and functional enrichment analysis of LTB4R in patients with acute myeloid leukemia].
Zhang X; Zhang X; Liu P; Liu K; Li W; Chen Q; Ma W
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Mar; 42(3):309-320. PubMed ID: 35426793
[TBL] [Abstract][Full Text] [Related]
14. High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia.
Du W; He J; Zhou W; Shu S; Li J; Liu W; Deng Y; Lu C; Lin S; Ma Y; He Y; Zheng J; Zhu J; Bai L; Li X; Yao J; Hu D; Gu S; Li H; Guo A; Huang S; Feng X; Hu D
J Transl Med; 2019 Jun; 17(1):191. PubMed ID: 31171000
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive bioinformatic analysis of the expression and prognostic significance of TSC22D domain family genes in adult acute myeloid leukemia.
Xu X; Sun R; Li Y; Wang J; Zhang M; Xiong X; Xie D; Jin X; Zhao M
BMC Med Genomics; 2023 May; 16(1):117. PubMed ID: 37237254
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatics Analysis Identifies Key Genes and Pathways in Acute Myeloid Leukemia Associated with DNMT3A Mutation.
Chen S; Chen Y; Lu J; Yuan D; He L; Tan H; Xu L
Biomed Res Int; 2020; 2020():9321630. PubMed ID: 33299888
[TBL] [Abstract][Full Text] [Related]
17. High Expression of ACOT2 Predicts Worse Overall Survival and Abnormal Lipid Metabolism: A Potential Target for Acute Myeloid Leukemia.
Yin X; Lyu C; Li Z; Wang Q; Ding Y; Wang Y; Qiu Y; Cui S; Guo D; Xu R
J Healthc Eng; 2022; 2022():2669114. PubMed ID: 36193167
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of Tim-3 is associated with poor prognosis in acute myeloid leukemia.
Wu Z; Ou J; Liu N; Wang Z; Chen J; Cai Z; Liu X; Yu X; Dai M; Zhou H
Cancer Med; 2023 Apr; 12(7):8956-8969. PubMed ID: 36545697
[TBL] [Abstract][Full Text] [Related]
19. Novel Prognostic Signature for Acute Myeloid Leukemia: Bioinformatics Analysis of Combined CNV-Driven and Ferroptosis-Related Genes.
Han C; Zheng J; Li F; Guo W; Cai C
Front Genet; 2022; 13():849437. PubMed ID: 35559049
[No Abstract] [Full Text] [Related]
20. [Clinical Significance of Low Expression of LncRNA CASC15 in Acute Myeloid Leukemia with NPM1 Mutations].
Xia PH; Xu ZJ; Jin Y; Ma JC; Wen XM; Yuan Q; Leng JY; Qian J; Lin J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):659-670. PubMed ID: 35680788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
